Anteilseigner
Frazier Life Sciences Management LP (13,70 %) Forbion Capital Partners Management Holding BV (13,25 %) Bain Capital Life Sciences LP (11,73 %) Viking Global Investors LP (8,99 %) RA Capital Management LP (8,81 %) Morningside Group Ltd. (4,55 %) Medicxi Ventures (Jersey) Ltd. (3,21 %) Deerfield Management Co. LP (2,78 %) Adage Capital Management LP (2,04 %) Cormorant Asset Management LP (1,68 %) Mitsubishi Chemical Group (1,63 %) Ascendant BioCapital (1,44 %) Goldman Sachs & Co. LLC (Private Banking) (1,44 %) Polar Capital LLP (1,40 %) Millennium Management LLC (1,06 %) GMT Capital Corp. (1,06 %) Jennison Associates LLC (1,04 %) Invus Public Equities Advisors LLC (0,90 %)
Kontakt
FRAZIER LIFESCIENCES ACQUISITN CORP